Your browser doesn't support javascript.
loading
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations.
Lu, Shun; Fang, Jian; Li, Xingya; Cao, Lejie; Zhou, Jianying; Guo, Qisen; Liang, Zongan; Cheng, Ying; Jiang, Liyan; Yang, Nong; Han, Zhigang; Shi, Jianhua; Chen, Yuan; Xu, Hua; Zhang, Helong; Chen, Gongyan; Ma, Rui; Sun, Sanyuan; Fan, Yun; Fan, Songhua; Yu, Jie; Lu, Puhan; Luo, Xian; Su, Weiguo.
Afiliação
  • Lu S; Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Fang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Oncology II, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Li X; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Cao L; Department of Respiratory Diseases, The First Affiliated Hospital of the University of Science and Technology of China, Anhui Provincial Hospital, Hefei, People's Republic of China.
  • Zhou J; Department of Respiratory Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Guo Q; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China.
  • Liang Z; Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Cheng Y; Department of Medical Thoracic Oncology, Jilin Cancer Hospital, Changchun, People's Republic of China.
  • Jiang L; Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Yang N; Department of Lung Cancer and Gastroenterology, Hunan Cancer Hospital, The Affiliated Tumour Hospital of Xiangya Medical School of Central South University, Changsha, People's Republic of China.
  • Han Z; First Department of Lung Cancer Chemotherapy, The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, People's Republic of China.
  • Shi J; Department of Oncology, Linyi Cancer Hospital, Linyi, People's Republic of China.
  • Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Xu H; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Zhang H; Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'An, People's Republic of China.
  • Chen G; Department of Medical Oncology, The Affiliated Tumour Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Ma R; Medical Oncology Department of Thoracic Cancer, Liaoning Cancer Hospital, Shenyang, People's Republic of China.
  • Sun S; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou, People's Republic of China.
  • Fan Y; Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
  • Fan S; HUTCHMED Limited, Shanghai, People's Republic of China.
  • Yu J; HUTCHMED Limited, Shanghai, People's Republic of China.
  • Lu P; HUTCHMED Limited, Shanghai, People's Republic of China.
  • Luo X; HUTCHMED Limited, Shanghai, People's Republic of China.
  • Su W; HUTCHMED Limited, Shanghai, People's Republic of China.
JTO Clin Res Rep ; 3(10): 100407, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36217329
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article